At AbbVie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.

We provide expertise and 'know how' in Europe to develop, commercialise and manufacture products that offer real value to payers, healthcare professionals and patients.

We believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about transforming patients’ lives. We are courageous in both decision and action. And we believe that good business means a better world.

The Pharmaceuticals Division, our largest in terms of sales, is focused on the following areas in which we aim to make decisive contributions to medical progress: oncology, cardiology and hematology, gynecology, neurology, infectious diseases, men’s health, ophthalmology, and diagnostic imaging.

CSL Behring is a leading global biotech company, that develops and delivers innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions live full lives.

Dr. Falk Pharma GmbH is an independent family firm based in Freiburg im Breisgau. In spite of its international presence, Dr. Falk Pharma and its 200 staff are still closely linked with the Freiburg region and the University of Freiburg. Our company specializes in the development and sales of medication for indications in hepatology and gastroenterology. These, mainly prescription drugs, are sold not only in Germany but also in a further 65 countries, often in co-operation with local partners but in some cases also via our own subsidiary companies.

Echosens is an innovative high-technology company offering a full range of products and services supporting physicians in their assessment and management of patients with chronic liver diseases.

Our vision for Sobi is to be recognised as a global leader in providing innovative treatments that transform lives for individuals with rare diseases.